Literature DB >> 8386272

Vaccinia virus morphogenesis is blocked by a temperature-sensitive mutation in the I7 gene that encodes a virion component.

E M Kane1, S Shuman.   

Abstract

The ts16 mutation of vaccinia virus WR (R. C. Condit, A. Motyczka, and G. Spizz, Virology 128:429-443, 1983) has been mapped by marker rescue to the I7L open reading frame located within the genomic HindIII I DNA fragment. The I7 gene encodes a 423-amino-acid polypeptide. Thermolabile growth was attributed to an amino acid substitution, Pro-344-->Leu, in the predicted I7 protein. A normal temporal pattern of viral protein synthesis was elicited in cells infected with ts16 at the nonpermissive temperature (40 degrees C). Electron microscopy revealed a defect in virion assembly at 40 degrees C. Morphogenesis was arrested at a stage subsequent to formation of spherical immature particles. Western immunoblot analysis with antiserum directed against the I7 polypeptide demonstrated an immunoreactive 47-kDa polypeptide accumulating during the late phase of synchronous vaccinia virus infection. Immunoblotting of extracts of wild-type virions showed that the I7 protein is encapsidated within the virus core. The I7 polypeptide displays amino acid sequence similarity to the type II DNA topoisomerase of Saccharomyces cerevisiae.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386272      PMCID: PMC237591     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Vaccinia virus reexamined: development and release.

Authors:  C Morgan
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

2.  Purification and characterization of a superhelix binding protein from vaccinia virus.

Authors:  S Y Kao; E Ressner; J Kates; W R Bauer
Journal:  Virology       Date:  1981-06       Impact factor: 3.616

3.  Biogenesis of vaccinia: involvement of spicules of the envelope during virion assembly examined by means of conditional lethal mutants and serology.

Authors:  K Essani; R Dugre; S Dales
Journal:  Virology       Date:  1982-04-30       Impact factor: 3.616

4.  Complementation and genetic linkage between vaccinia virus temperature-sensitive mutants.

Authors:  R Drillien; D Spehner; A Kirn
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

5.  Isolation and preliminary characterization of temperature-sensitive mutants of vaccinia virus.

Authors:  R C Condit; A Motyczka
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

6.  Isolation and genetic characterization of temperature-sensitive mutants of vaccinia virus WR.

Authors:  M J Ensinger
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

7.  Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus.

Authors:  R C Condit; A Motyczka; G Spizz
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

8.  Structure and function of the region of the replication origin of the Bacillus subtilis chromosome. III. Nucleotide sequence of some 10,000 base pairs in the origin region.

Authors:  S Moriya; N Ogasawara; H Yoshikawa
Journal:  Nucleic Acids Res       Date:  1985-04-11       Impact factor: 16.971

9.  Location of DNA-binding proteins and disulfide-linked proteins in vaccinia virus structural elements.

Authors:  Y Ichihashi; M Oie; T Tsuruhara
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

10.  Vaccinia virus RNA helicase: an essential enzyme related to the DE-H family of RNA-dependent NTPases.

Authors:  S Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

View more
  41 in total

1.  Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: isolation of a dominant, temperature-sensitive mutant with a profound defect in morphogenesis.

Authors:  J DeMasi; P Traktman
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis.

Authors:  W W Yeh; B Moss; E J Wolffe
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Molecular dissection of the vaccinia virus I7L core protein proteinase.

Authors:  Chelsea M Byrd; Tove' C Bolken; Dennis E Hruby
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

4.  The vaccinia virus I7L gene product is the core protein proteinase.

Authors:  Chelsea M Byrd; Tove' C Bolken; Dennis E Hruby
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  Role of the I7 protein in proteolytic processing of vaccinia virus membrane and core components.

Authors:  Camilo Ansarah-Sobrinho; Bernard Moss
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

6.  Activity, specificity, and probe design for the smallpox virus protease K7L.

Authors:  Alexander E Aleshin; Marcin Drag; Naran Gombosuren; Ge Wei; Jowita Mikolajczyk; Arnold C Satterthwait; Alex Y Strongin; Robert C Liddington; Guy S Salvesen
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

7.  Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein.

Authors:  J R Rodríguez; C Risco; J L Carrascosa; M Esteban; D Rodríguez
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  The vaccinia virus G1L putative metalloproteinase is essential for viral replication in vivo.

Authors:  Marika Hedengren-Olcott; Chelsea M Byrd; Jeffrey Watson; Dennis E Hruby
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  DNA packaging mutant: repression of the vaccinia virus A32 gene results in noninfectious, DNA-deficient, spherical, enveloped particles.

Authors:  M C Cassetti; M Merchlinsky; E J Wolffe; A S Weisberg; B Moss
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Vaccinia virus G1 protein, a predicted metalloprotease, is essential for morphogenesis of infectious virions but not for cleavage of major core proteins.

Authors:  Camilo Ansarah-Sobrinho; Bernard Moss
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.